newsfilter
← Latest News
Business Wire·

Gemini Therapeutics Announces Presentation at 2nd Annual Dry AMD Therapeutic Development Summit

Gemini Therapeutics, Inc. (NASDAQ:GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration (AMD), today announced Chief Medical Officer, Samuel Barone, M.D., will presen